|1.||Hunzelmann, N: 2 articles (10/2005 - 08/2001)|
|2.||Brinckmann, J: 2 articles (10/2005 - 08/2001)|
|3.||Notbohm, H: 2 articles (10/2005 - 08/2001)|
|4.||Yang, Yanan: 1 article (03/2015)|
|5.||Martinez, Elisabeth D: 1 article (03/2015)|
|6.||Puperi, Daniel S: 1 article (03/2015)|
|7.||Burns, Alan R: 1 article (03/2015)|
|8.||Zal, Tomasz: 1 article (03/2015)|
|9.||Scott, Kenneth L: 1 article (03/2015)|
|10.||Behrens, Carmen: 1 article (03/2015)|
01/01/1992 - "Urinary excretion of galactosyl hydroxylysine, which is increased in the presence of progressive increased bone resorption, remained within normal values in the patients of this study. "
05/01/1999 - "Serum galactosyl hydroxylysine as a biochemical marker of bone resorption."
07/01/1993 - "Galactosyl hydroxylysine and deoxypyridinoline are at present the most promising markers of bone resorption. "
11/01/1992 - "Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared."
08/01/1992 - "Further evidence of elevated bone resorption in Ullrich-Turner syndrome by measuring urinary galactosyl-hydroxylysine."
|3.||Collagen Diseases (Collagen Disease)
01/28/1980 - "The collagenous part of C1q is unaffected in the hydroxylysine-deficient collagen disease."
05/11/1972 - "Hydroxylysine-deficient collagen disease."
07/01/1982 - "Patients with hydroxylysine-deficient collagen disease (Ehlers-Danlos type VI) have diminished lysyl hydroxylase activity. "
09/01/1985 - "The studies suggest the existence in cultured cells of a compensatory mechanism for overproduction of these crucial enzymes in collagen biosynthesis, a mechanism which remains functional in cells derived from patients afflicted with hydroxylysine-deficient collagen disease."
04/01/1999 - "We investigated the effect of 3 agents that in earlier studies were found to inhibit KATP channels--NG-nitro-L-arginine, hydroxylysine, and glyburide--on the cerebral arteriolar constriction caused by graded hypocapnia induced by hyperventilation in anesthetized cats equipped with cranial windows. "
|5.||Liver Diseases (Liver Disease)
10/01/1989 - "In 33 patients with liver disease, the urinary excretion of hydroxyproline and hydroxylysine and the hepatic content of hydroxyproline were increased in proportion to the severity of liver disease. "
10/01/1989 - "In patients with or without various chronic liver diseases, the total urinary excretion of hydroxyproline and hydroxylysine and the hepatic content of hydroxyproline were examined. "
10/01/1989 - "Urinary hydroxyproline and hydroxylysine excretions in relation to hepatic hydroxyproline content in chronic liver disease."
10/01/1989 - "These results suggest that the study of urinary hydroxyproline and hydroxylysine excretion may yield useful information on the metabolism of hepatic collagen in chronic liver disease. "
10/01/1989 - "In 7 patients without liver disease, the urinary excretion of hydroxyproline and hydroxylysine were 10.3 +/- 1.5 and 1.31 +/- 0.21 mmol/mol creatinine, respectively, and the hepatic content of hydroxyproline was 4.9 +/- 0.6 mumol/g of wet liver. "
|1.||Hydroxyproline (4 Hydroxyproline)
|3.||Glycine (Aminoacetic Acid)
|4.||Gonadotropin-Releasing Hormone (GnRH)
|6.||Collagen Type I (Type I Collagen)
|7.||Aspartic Acid (Aspartate)
|9.||Nitroarginine (NG Nitro L Arginine)
|1.||Home Parenteral Nutrition